Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …

Background Accurate and rapid detection of tuberculosis (TB) and drug resistance are
critical for improving patient care and decreasing the spread of TB. Xpert® MTB/RIF assay …

Summary Background The Xpert MTB/RIF assay is an automated molecular test that has
improved the detection of tuberculosis and rifampicin resistance, but its sensitivity is …

Background Every year, an estimated one million children and young adolescents become
ill with tuberculosis, and around 226,000 of those children die. Xpert MTB/RIF Ultra (Xpert …

ОБНОВЛЁННЫЕ РЕКОМЕНДАЦИИ Page 1 Автоматизированная технология
амплификации нуклеиновых кислот в режиме реального времени для быстрого …

Global TB control efforts have been severely hampered by the lack of diagnostic tests that
are accurate, simple to use and can be applied at the point of clinical care. This has been …

Rapid progress has been made in the development of new diagnostic assays for
tuberculosis in recent years. New technologies have been developed and assessed, and …

Tuberculous meningitis (TBM) is the most severe form of tuberculosis. Microbiological
confirmation is rare, and treatment is often delayed, increasing mortality and morbidity. The …

Background WHO recommends that Xpert MTB/RIF replaces smear microscopy for initial
diagnosis of suspected HIV-associated tuberculosis or multidrug-resistant pulmonary …

The rapid diagnosis of rifampin resistance is hampered by a reported insufficient specificity
of molecular techniques for detection of rpoB mutations. Our objective for this study was to …